The Pharma Data

MAY 2, 2021

Holzkirchen, May 3, 2021 – Sandoz, a Novartis division, today announced progress in the late-stage clinical development program for its proposed biosimilar aflibercept. Sandoz will begin enrolling the first patient in MYLIGHT, a clinical Phase III confirmatory efficacy and safety study, shortly 1. Accessed April 2021].

Biosimilars 40

Biosimilars Clinical Development Production Government 40

Drug Discovery World

MAY 3, 2023

Adcendo, a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) for the treatment of cancers with a high unmet medical need, has completed a successful Series A extension financing round, raising a further €31 million, following the €51 million Series A financing in April 2021.

Licensing 130

Licensing Licensing Clinical Development Therapies 130

Drug Discovery World

APRIL 25, 2023

Pre-clinical research investigating the CAR-T cell therapy demonstrated an ability to potently suppress HIV and eliminate HIV-expressing cells in vitro and in animal models. In 2021 there were an estimated 1.5 Currently, there are approximately 38 million people living with HIV around the world.

Research 130

Research Clinical Trials Therapies Clinical Development 130

The Pharma Data

AUGUST 3, 2021

In the first half of 2021, Boehringer Ingelheim has supplied more humans and animals worldwide with innovative medicines than ever before. Our strong R&D pipeline has made further, decisive progress in the first half of 2021. In the first half of 2021, Boehringer Ingelheim generated strong net sales of around 2.3

Research 52

Research Clinical Trials Treatment Production 52

Cytel

OCTOBER 27, 2023

Since its launch in 2021, Project Optimus has been reforming the dose optimization and dose selection paradigm in oncology drug development. Most of these post-approval changes have been overall decreases in dose. To address this challenge, the FDA Oncology Center of Excellence initiated Project Optimus.

Clinical Trials 64

Clinical Trials Trials Clinical Pharmacology Clinical Development 64

The Pharma Data

JANUARY 20, 2021

20, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. The offering is expected to close on or about January 25, 2021, subject to satisfaction of customary closing conditions. SOUTH SAN FRANCISCO, Calif., Morgan Securities LLC, Cowen and Company, LLC and Piper Sandler are acting as joint bookrunning managers for the offering.

Clinical Development 40

Clinical Development Therapies Science Drugs 40

Drug Discovery World

DECEMBER 7, 2022

If clinical research into collagen maintains this momentum, we can expect to see innovations in wound healing and bone care making their way to patients in the coming years.”. In 2021, the global collagen market was valued at $9.75 billion USD, and is expected to grow to $16.7 billion by 2028.

Clinical Trials 130

Clinical Trials Trials Clinical Research Clinical Development 130

The Pharma Data

JANUARY 19, 2021

With this kind of a start, 2021 may be scorching. The company hopes to raise $140 million of common stock, which will be used to advance its clinical and earlier stage programs and for R&D, working capital and general corporate purposes. Last year was a record number of IPOs in the biotech industry, with 81 raising $13.5

Small Molecule 52

Small Molecule Laboratories Immune Response Trials 52

The Pharma Data

JANUARY 19, 2021

19, 2021 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. The offering is expected to close on January 22, 2021, subject to customary closing conditions. The company has advanced losmapimod to Phase 2 clinical development for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and Phase 3 for the treatment of COVID-19.

Small Molecule 40

Small Molecule Clinical Development Treatment Engineering 40

Drug Discovery World

MARCH 7, 2023

Dr Natalie Kenny, Founder and CEO, BioGrad In 2021, Dr Kenny won EVA’s Businesswoman of the Year award, The Business Desk top 50 City Region Leader for Liverpool and The Business Desk’s North West Investment Award. She was appointed as CEO of Novo Nordisk Pharmatech in 2021.

International 246

International Science Pharmaceuticals DNA 246

The Pharma Data

AUGUST 6, 2020

Under the pact, AZ will transfer the vaccine’s technology to BioKangtai, which will in return reserve enough capacity to make at least 100 million doses of the shot by the end of 2020 and expand to 200 million doses per year by the end of 2021. China has several home-grown COVID-19 vaccines in clinical development.

Vaccine 52

Vaccine Licensing Licensing Immune Response 52

KIF1A

MARCH 16, 2024

billion people were affected by neurological disorders in 2021, making them a leading cause of disability worldwide. While genetic disorders like KAND make up only a small part of this number, this represents the need for increased investment in neuroscience research and clinical development.

Disease 105

Disease Clinical Development Research Treatment 105

The Pharma Data

JANUARY 14, 2021

15, 2021 /PRNewswire/ — Calliditas Therapeutics AB (publ) (“Calliditas”) (Nasdaq OMX – CALTX) (NASDAQ – CALT) today announced the program for the upcoming virtual R&D Day for investors, analysts and journalists on January 20, 2021 , which will take place between 1pm and 5pm CET. STOCKHOLM , Jan.

Clinical Trials 40

Clinical Trials Hospitals Disease International 40

Drug Discovery World

APRIL 14, 2023

Dr Schon is applying his broad expertise from lead discovery to manufacture in order to progress differentiated, safe and developable bi-specific therapeutic ADC candidates to clinical development. Biography Oliver Schon, PhD, has been VP, R&D at BiVictriX Therapeutics since September 2021.

Drug Development 130

Drug Development Drugs Clinical Trials Therapies 130

The Pharma Data

JANUARY 20, 2021

20, 2021 /PRNewswire/ — INOVIO Pharmaceuticals, Inc. The offering is expected to close on or about January 25, 2021 , subject to customary closing conditions. PLYMOUTH MEETING, Pa. , Gross proceeds to INOVIO from the offering are expected to be approximately $150.5 All of the shares are being sold by INOVIO.

DNA 40

DNA Immune Response Disease Clinical Trials 40

Drug Discovery World

SEPTEMBER 6, 2022

As researchers and developers work to transform the way we treat diseases, cell and gene therapies will continue to be the centre of innovation in the coming years. . Record breaking investments in 2021 fuel an industry on fire . billion raised. However, the question remains as to whether this will continue in 2022.

Therapies 130

Therapies Clinical Trials Production Disease 130

Drug Discovery World

JULY 2, 2024

OECD data places Switzerland second in the world for biotechnology R&D intensity 1 , and in 2021, the country had the seventh largest share of the global biotech market 2. The centre currently has 58 pharma/biotech assets that are in pre-clinical development, alongside 29 that are being tested in clinical trials.

Science 147

Science Drugs Clinical Trials Licensing 147

The Pharma Data

JANUARY 18, 2021

18, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. The fireside chat is scheduled to take place on Wednesday, January 20, 2021 at 2:30 PM ET. The fireside chat is scheduled to take place on Wednesday, January 20, 2021 at 2:30 PM ET. © 2021 Sorrento Therapeutics, Inc. SAN DIEGO, Jan.

Small Molecule 40

Small Molecule Clinical Trials Trials Therapies 40

The Pharma Data

APRIL 11, 2021

The data were presented at the 2021 American Association for Cancer Research (AACR) Annual Meeting, held virtually April 10-15, 2021. was approved by the European Commission in February 2021. The Phase 1/2 LIBRETTO-001 trial is the largest clinical trial of patients with RET -driven cancers treated with a RET inhibitor.

Research 52

Research Therapies Treatment Trials 52

Drug Target Review

AUGUST 24, 2023

She joined the company in November 2018 with more than 10 years of experience in drug discovery and non-clinical development of immunomodulatory drugs in the immuno-oncology space. 2021 Jul 6;120(13):2644-56. 2021 Dec 1;9(12):1425-38. 2021 Jun 17;12:685370. 2021 Nov 1;41. Biophysical Journal.

Treatment 98

Treatment Therapies Clinical Development Cell Biology 98

Drug Discovery World

JULY 11, 2022

2021, February 23). " September 14, 2021.Pharma's " July21, 2021. Methods& clinical development, 21,524–529. Krishnan, M., &Davies, C (2021). "UnchartedTerritory: "UnchartedTerritory: Top Challenges Facing Gene Therapy Development."

Therapies 130

Therapies Clinical Trials Production Trials 130

The Pharma Data

MAY 2, 2023

Bonello has more than 30 years of financial leadership experience, including 15 years in the clinical research industry. a clinical trial data collection company, since 2021. From 2008 to 2021, Mr. Bonello held roles of increasing responsibility at Nasdaq-listed PRA Health Sciences, Inc.,

Clinical Trials 40

Clinical Trials Clinical Research Science Clinical Development 40

The Pharma Data

DECEMBER 9, 2020

Initial results for the open-label study are expected in 2021. It has shown remarkably high safety and tolerability measure during non-clinical development. . The total transaction value for the acquisition also includes contingent clinical and regulatory milestones and is set to close in early 2021. .

FDA Approval 52

FDA Approval Clinical Development Vaccine Therapies 52

Cytel

OCTOBER 11, 2023

Moving beyond static evidence development to ensure local market access success; responding to recent changes in governmental drug regulations and the role of automation Written by Grammati Sarri and Radek Wasiak The worldwide drug regulation landscape is rapidly changing.

Marketing 59

Marketing Pharmaceutical Companies Regulations Pharmaceuticals 59

The Pharma Data

JANUARY 4, 2021

05, 2021 (GLOBE NEWSWIRE) — Polyphor AG (SIX: POLN) announced today that Gökhan Batur, Chief Executive Officer, will take part in a panel discussion at the LifeSci Partners 10th Annual Healthcare Corporate Access Event on Thursday, January 7 from 8:00AM Eastern Standard Time. ALLSCHWIL, Switzerland, Jan.

Clinical Development 52

Clinical Development Trials Treatment Research 52

The Pharma Data

JANUARY 26, 2021

27, 2021 07:00 UTC. LEIDEN, The Netherlands–( BUSINESS WIRE )– VarmX , a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces the appointment of Dr. Gerard Short, MBBS, as Chief Medical Officer (CMO).

Clinical Development 40

Clinical Development Medical Schools Therapies Pharmaceuticals 40

The Pharma Data

JANUARY 12, 2021

13, 2021 /PRNewswire/ — EVOQ Therapeutics today announced a license and collaboration agreement with Amgen for the discovery and development of novel drugs for autoimmune disorders. ANN ARBOR, Mich. ,

Licensing 52

Licensing Licensing Biosimilars Clinical Development 52

Drug Discovery World

MAY 6, 2024

billion on R&D during 2021, with Germany and Switzerland being the biggest contributors, and around one fourth of clinical trials worldwide were performed in Europe 1. During the period 2016-2021, the Brazilian, Chinese and Indian markets grew by 11.7%, 6.7% respectively compared to an average market growth of 5.8%

Drugs 147

Drugs Molecular Biology Science Clinical Trials 147

FDA Law Blog: Biosimilars

AUGUST 8, 2023

The Guidance, which provides details about nitrosamines and FDA’s experience regulating them, explicitly applies to all finished drug products (including Rx, OTC, and unauthorized drugs), to “prescription and OTC drug products in clinical development,” and to both API and drug manufacturers. An earlier FDA guidance, revised in 2021.

FDA 74

FDA Organic Chemistry Drugs Production 74

The Pharma Data

JANUARY 12, 2021

13, 2021 (GLOBE NEWSWIRE) — Leading Biosciences , Inc. (“LBS”), The FDA Fast Track program is intended to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need. CARLSBAD, Calif., Nasdaq: SNCA) to form Palisade Bio, Inc., announced that the U.S. Tom Hallam, Ph.D.,

FDA 52

FDA Treatment Trials Hospitals 52

The Pharma Data

JANUARY 5, 2021

COVID-19 have caused delays to submission and processing of the regulatory application to initiate clinical development in China. Due to the unforeseen delays, Targovax has extended the term of IOvaxis’s license option by 3 months, otherwise the agreement remains unchanged. OSLO, Norway , Jan.

Licensing 40

Licensing Licensing Vaccine Clinical Development 40

The Pharma Data

JANUARY 21, 2021

22, 2021 12:00 UTC. –( BUSINESS WIRE )– Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced an oral presentation on updated efficacy, safety, and dosing management of poziotinib from Cohorts 1 and 2 of the ZENITH20 clinical trial.

Pharmaceuticals 52

Pharmaceuticals Clinical Trials Licensing Licensing 52

The Pharma Data

MARCH 27, 2021

Dr. Martin will assume responsibility for Gilead’s research organization effective April 12, 2021. (Nasdaq: GILD) today announced that Flavius Martin, MD will join the company as Executive Vice President, Research, and will become a member of the company’s senior leadership team, reporting to Chairman and Chief Executive Officer Daniel O’Day.

Science 52

Science Research Pharmacy Clinical Development 52

Drug Discovery World

DECEMBER 22, 2022

For example, as part of the American Rescue Plan of 2021, the United States (US) established the Center for Forecasting and Outbreak Analytics. She also consults with small to mid-size biotechnology clients and large pharmaceutical companies providing strategic operational guidance and driving partnership development. .

Vaccine 130

Vaccine Disease Clinical Trials Trials 130

The Pharma Data

NOVEMBER 18, 2021

Gilead has been encouraged by early clinical data generated for each of the three programs. By concluding in early to all three programs now, Gilead and Arcus are suitable to accelerate the clinical development and advancement of these clinical- stage motes and grease the disquisition of treatment combinations across the portfolios.

Research 52

Research Small Molecule Clinical Development Packaging 52

The Pharma Data

SEPTEMBER 2, 2020

If successful, the companies intend to request regulatory approval in the first half of 2021. Sanofi and GSK are currently scaling up manufacturing of the antigen and adjuvant with the target of producing up to one billion doses in 2021.

Vaccine 52

Vaccine Trials Immune Response Clinical Trials 52

The Pharma Data

JANUARY 13, 2021

13, 2021 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced that the U.S. A presentation of interim data is anticipated in 2021, with initiation of a dose expansion cohort in the second half of 2021.

FDA 52

FDA Treatment Clinical Trials Trials 52